The sul1 Gene in Stenotrophomonas maltophilia With High-Level Resistance to Trimethoprim/Sulfamethoxazole
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Emerging resistance to trimethoprim/sulfamethoxazole (SXT) poses a serious threat to the treatment of Stenotrophomonas maltophilia infections. We determined the prevalence and molecular characteristics of acquired SXT resistance in recent clinical S. maltophilia isolates obtained from Korea. A total of 252 clinical isolates of S. maltophilia were collected from 10 university hospitals in Korea between 2009 and 2010. Antimicrobial susceptibility was determined by using the CLSI agar dilution method. The sul1, sul2, and sul3 genes, integrons, insertion sequence common region (ISCR) elements, and dfrA genes were detected using PCR. The presence of the sul1 gene and integrons was confirmed through sequence analysis. Among the 32 SXT-resistant isolates, sul1 was detected in 23 isolates (72%), all of which demonstrated high-level resistance (≥64 mg/L) to SXT. The sul1 gene (varying in size and structure) was linked to class 1 integrons in 15 of the 23 isolates (65%) harboring this gene. None of the SXT-susceptible isolates or the SXT-resistant isolates with a minimum inhibitory concentration of 4 and 8 mg/L were positive for sul1. Moreover, the sul2, sul3, and dfrA genes or the ISCR elements were not detected. The sul1 gene may play an important role in the high-level SXT resistance observed in S. maltophilia.
Abstract
Emerging resistance to trimethoprim/sulfamethoxazole (SXT) poses a serious threat to the treatment of Stenotrophomonas maltophilia infections. We determined the prevalence and molecular characteristics of acquired SXT resistance in recent clinical S. maltophilia isolates obtained from Korea. A total of 252 clinical isolates of S. maltophilia were collected from 10 university hospitals in Korea between 2009 and 2010. Antimicrobial susceptibility was determined by using the CLSI agar dilution method. The sul1, sul2, and sul3 genes, integrons, insertion sequence common region (ISCR) elements, and dfrA genes were detected using PCR. The presence of the sul1 gene and integrons was confirmed through sequence analysis. Among the 32 SXT-resistant isolates, sul1 was detected in 23 isolates (72%), all of which demonstrated high-level resistance (≥64 mg/L) to SXT. The sul1 gene (varying in size and structure) was linked to class 1 integrons in 15 of the 23 isolates (65%) harboring this gene. None of the SXT-susceptible isolates or the SXT-resistant isolates with a minimum inhibitory concentration of 4 and 8 mg/L were positive for sul1. Moreover, the sul2, sul3, and dfrA genes or the ISCR elements were not detected. The sul1 gene may play an important role in the high-level SXT resistance observed in S. maltophilia.
참고문헌 (16)
- Looney WJ, "Stenotrophomonas maltophilia: an emerging opportunist human pathogen", Lancet Infect Dis, 9, pp.312~323 (2009)
- Brooke JS, "Stenotrophomonas maltophilia: an emerging global opportunistic pathogen", Clin Microbiol Rev, 25, pp.2~41 (2012)
- Farrell DJ, "Antimicrobial susceptibilities of a worldwide collection of Stenotrophomonas maltophilia isolates tested against tigecycline and agents commonly used for S. maltophilia infections", Antimicrob Agents Chemother, 54, pp.2735~2737 (2010)
- Tan CK, "Extensively drug-resistant Stenotrophomonas maltophilia in a tertiary care hospital in Taiwan: microbiologic characteristics, clinical features, and outcomes", Diagn Microbiol Infect Dis, 60, pp.205~210 (2008)
- Al-Jasser AM, "Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: an increasing problem", Ann Clin Microbiol Antimicrob, 5, pp.23~ (2006)
- Barbolla R, "Class 1 integrons increase trimethoprim-sulfamethoxazole MICs against epidemiologically unrelated Stenotrophomonas maltophilia isolates", Antimicrob Agents Chemother, 48, pp.666~669 (2004)
- Toleman MA, "Global emergence of trimethoprim", sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes, 2007, pp.13, 559~565
- Hu LF, "Stenotrophomonas maltophilia resistance to trimethoprim", sulfamethoxazole mediated by acquisition of sul and dfrA genes in a plasmid-mediated class 1 integron, 2011, pp.37, 230~234
- Chang LL, "Increased incidence of class 1 integrons in trimethoprim", sulfamethoxazole-resistant clinical isolates of Stenotrophomonas maltophilia, 2007, pp.59, 1038~1039
- 송정훈, "Analysis of Acquired Resistance Genes in Stenotrophomonas maltophilia", Annals of Laboratory Medicine, 30(3), pp.295~300 (2010), 대한진단검사의학회
- Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing.Twenty-first informational supplement, M100-S21", Clinical and Laboratory Standards Institute, ~ (2011)
- Perreten V, "A new sulfonamide resistance gene (sul3) in Escherichia coli is widespread in the pig population of Switzerland", Antimicrob Agents Chemother, 47, pp.1169~1172 (2003)
- Bae IK, "Novel complex class 1 integron bearing an ISCR1 element in an Escherichia coli isolate carrying the blaCTX-M-14 gene", Antimicrob Agents Chemother, 51, pp.3017~3019 (2007)
- Seputiene V, "Suziedéliené E. Prevalence of trimethoprim resistance genes in Escherichia coli isolates of human and animal origin in Lithuania", J Med Microbiol, 59, pp.315~322 (2010)
- 정혜선, "Antimicrobial Susceptibility of Stenotrophomonas maltophilia Isolates from Korea, and the Activity of Antimicrobial Combinations against the Isolates", Journal of Korean Medical Science, 28(1), pp.62~66 (2013), 대한의학회
- Baquero F, "Low-level antibacterial resistance: a gateway to clinical resistance", Drug Resist Updat, 4, pp.93~105 (2001)